Market capitalization | SEK4.76b |
Enterprise Value | SEK4.60b |
P/E (TTM) P/E ratio | 31.22 |
EV/FCF (TTM) EV/FCF | 43.09 |
EV/Sales (TTM) EV/Sales | 6.15 |
P/S ratio (TTM) P/S ratio | 6.36 |
P/B ratio (TTM) P/B ratio | 5.67 |
Dividend yield | 1.26% |
Last dividend (FY24) | SEK2.50 |
As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.
3 Analysts have issued a CellaVision forecast:
3 Analysts have issued a CellaVision forecast:
Mar '25 |
+/-
%
|
||
Revenue | 748 748 |
6%
6%
|
|
Gross Profit | 512 512 |
7%
7%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 196 196 |
8%
8%
|
Net Profit | 152 152 |
8%
8%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The firm's products include Analyzers, Instruments, DIFF-Line™ by CellaVision, Reagents, and Software and applications. It operates through the following geographical segments: Americas, APAC, and EMEA. The company was founded by Lars Christer Fedrik Fåhraeus on November 16, 1994 and is headquartered in Lund, Sweden.
Head office | Sweden |
CEO | Simon Ostergaard |
Employees | 219 |
Founded | 1994 |
Website | www.cellavision.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.